Keyword | CPC | PCC | Volume | Score | Length of keyword |
---|---|---|---|---|---|
imfinzi durvalumab biggest company | 0.81 | 1 | 3927 | 59 | 34 |
imfinzi | 0.97 | 0.1 | 9996 | 18 | 7 |
durvalumab | 1.81 | 0.5 | 2105 | 35 | 10 |
biggest | 0.94 | 0.6 | 2999 | 12 | 7 |
company | 1.49 | 0.5 | 6304 | 40 | 7 |
Keyword | CPC | PCC | Volume | Score |
---|---|---|---|---|
imfinzi durvalumab biggest company | 0.2 | 0.3 | 7043 | 80 |
imfinzi durvalumab biggest comparison | 1.32 | 0.7 | 2405 | 76 |
imfinzi durvalumab biggest customer | 1.08 | 1 | 7110 | 64 |
imfinzi durvalumab biggest commercial | 0.54 | 0.9 | 7963 | 51 |
imfinzi durvalumab biggest collaboration | 1.59 | 0.3 | 3788 | 56 |
imfinzi durvalumab biggest competitor in cost | 0.33 | 0.7 | 4153 | 73 |
imfinzi durvalumab biggest competitor | 0.77 | 0.2 | 1398 | 73 |
imfinzi durvalumab biggest clinical trial | 0.83 | 0.1 | 5144 | 96 |
imfinzi durvalumab biggest controversy | 0.13 | 0.5 | 4771 | 46 |
imfinzi durvalumab biggest challenge | 0.48 | 0.8 | 3804 | 30 |
durvalumab imfinzi package insert | 1.3 | 0.3 | 8587 | 48 |
j code for imfinzi durvalumab | 1.67 | 0.7 | 6992 | 4 |
imfinzi durvalumab side effects | 1.88 | 0.6 | 5711 | 12 |
cpt code for durvalumab imfinzi | 0.02 | 0.1 | 9487 | 89 |
imfinzi biggest competitor in clinical trials | 0.58 | 0.7 | 5578 | 40 |
imfinzi biggest competitor in cost | 1.89 | 0.7 | 5677 | 21 |
imfinzi biggest competitor in market share | 1.29 | 0.3 | 7046 | 59 |